摘要
分化型甲状腺癌(DTC)准确的分期和危险性分层对DTC患者个体化治疗和随访方案的制订非常重要。目前DTC标准的治疗模式是手术+131I治疗+促甲状腺激素(TSH)抑制治疗。欧美国家多采用全或近全甲状腺切除术,国内则较为保守。全或近全甲状腺切除术可以提供准确的术后分期依据,便于随后进行131I治疗,并且可以提高血清甲状腺球蛋白测定对DTC随访的准确性。131I治疗是DTC术后首选的治疗方法,有独特而重要的作用。TSH抑制治疗应采用个体化的抑制目标。
The precise staging and risk stratification of differentiated thyroid cancer( DTC) are important to formulate individual treatment and follow-up schemes for DTC patients. At present,the standard treatment pattern of DTC is surgery +131I + thyroid stimulating hormone( TSH) suppression therapy. Total or subtotal thyroidectomy is mostly used in European and American countries,while it is more conservative in China.Total or subtotal thyroidectomy is beneficial to precise postoperative staging,subsequent131 I therapy and tumor follow-up with Tg measurement.131 I therapy is first choice for postoperative DTC,which has a unique and important role. TSH suppression therapy should adopt individual suppression target.
出处
《医学综述》
2016年第10期1910-1913,共4页
Medical Recapitulate
